Connect with us


Americans With ALS Look to Canada for Promising Drug the U.S. Hasn’t Approved



#People #ALS #Canada #Promising #Drug #Hasnt #Permitted

Canada permitted Amylyx Prescribed drugs Inc.’s new drug for amyotrophic lateral sclerosis final week. Now some U.S. sufferers with the deadly neurodegenerative dysfunction—also called Lou Gehrig’s illness—are contemplating a visit north to get the medicine, Albrioza. The drug isn’t approved in the U.S.

William Woods, a 75-year-old retired physician in Atlanta who was identified with ALS in 2019, is contacting Canadian medical doctors who would possibly assist him get Albrioza. “There’s a lot to determine,” he mentioned, “however I’m assured I’ll discover someone I can go see.”